153182-63-9 Usage
Description
(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(2-ethoxyethyl)-5,6-dihydroxy-1,3-di azepan-2-one is a complex organic compound characterized by its unique molecular structure. It features two benzyl groups, two ethoxyethyl groups, and two hydroxy groups, all arranged in a specific 3D configuration as indicated by the (4R,5S,6S,7R) stereochemistry. The presence of a diazepan ring, a common structural motif in pharmaceutical compounds, suggests potential pharmacological applications for this chemical. Its complex nature and potential activities make it a compound of interest to researchers in the field of medicinal chemistry.
Uses
Used in Pharmaceutical Industry:
(4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(2-ethoxyethyl)-5,6-dihydroxy-1,3-di azepan-2-one is used as a potential pharmaceutical compound for its possible applications in drug development. The presence of the diazepan ring and the compound's stereochemistry suggest that it may have specific biological activities, making it a candidate for further research and development in the creation of new medications.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(2-ethoxyethyl)-5,6-dihydroxy-1,3-di azepan-2-one is used as a subject of study for understanding its pharmacological properties. (4R,5S,6S,7R)-4,7-dibenzyl-1,3-bis(2-ethoxyethyl)-5,6-dihydroxy-1,3-di azepan-2-one's complex structure and potential interactions with biological targets make it a valuable tool for exploring new avenues in drug discovery and design.
Check Digit Verification of cas no
The CAS Registry Mumber 153182-63-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,3,1,8 and 2 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 153182-63:
(8*1)+(7*5)+(6*3)+(5*1)+(4*8)+(3*2)+(2*6)+(1*3)=119
119 % 10 = 9
So 153182-63-9 is a valid CAS Registry Number.
InChI:InChI=1/C27H38N2O5/c1-3-33-17-15-28-23(19-21-11-7-5-8-12-21)25(30)26(31)24(20-22-13-9-6-10-14-22)29(27(28)32)16-18-34-4-2/h5-14,23-26,30-31H,3-4,15-20H2,1-2H3/t23-,24-,25+,26+/m1/s1
153182-63-9Relevant articles and documents
Cyclic HIV protease inhibitors: Synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureas
Lam, Patrick Y. S.,Ru, Yu,Jadhav, Prabhakar K.,Aldrich, Paul E.,DeLucca, George V.,Eyermann, Charles J.,Chang, Chong-Hwan,Emmett, George,Holler, Edward R.,Daneker, Wayne F.,Li, Liangzhu,Confalone, Pat N.,McHugh, Robert J.,Han, Qi,Li, Renhua,Markwalder, Jay A.,Seitz, Steven P.,Sharpe, Thomas R.,Bacheler, Lee T.,Rayner, Marlene M.,Klabe, Ronald M.,Shum, Linyee,Winslow, Dean L.,Kornhauser, David M.,Jackson, David A.,Erickson-Viitanen, Susan,Hodge, C. Nicholas
, p. 3514 - 3525 (2007/10/03)
High-resolution X-ray structures of the complexes of HIV-1 protease (HIV-1PR) with peptidomimetic inhibitors reveal the presence of a structural water molecule which is hydrogen bonded to both the mobile flaps of the enzyme and the two carbonyls flanking
